Extended-release naltrexone overlooked in opioid use disorders guideline

被引：1
|
作者：
Rieb, Launette M. [1 ]
机构：
[1] Univ British Columbia, Fac Med, Dept Family Practice, Vancouver, BC, Canada
来源：
CANADIAN MEDICAL ASSOCIATION JOURNAL | 2018年 / 190卷 / 28期
关键词：
RANDOMIZED CONTROLLED-TRIAL; BUPRENORPHINE-NALOXONE; MEDICATIONS; DEPENDENCE;
D O I：
10.1503/cmaj.69411
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E862 / E862
页数：1
相关论文
共 50 条
  • [21] Extended-Release Naltrexone to Prevent Opioid Relapse in Criminal Justice Offenders
    Lee, Joshua D.
    Friedmann, Peter D.
    Kinlock, Timothy W.
    Nunes, Edward V.
    Boney, Tamara Y.
    Hoskinson, Randall A., Jr.
    Wilson, Donna
    McDonald, Ryan
    Rotrosen, John
    Gourevitch, Marc N.
    Gordon, Michael
    Fishman, Marc
    Chen, Donna T.
    Bonnie, Richard J.
    Cornish, James W.
    Murphy, Sean M.
    O'Brien, Charles P.
    NEW ENGLAND JOURNAL OF MEDICINE, 2016, 374 (13): : 1232 - 1242
  • [22] Extended-Release Naltrexone for Alcohol and Opioid Problems in Missouri Parolees and Probationers
    Crits-Christoph, Paul
    Lundy, Christie
    Stringer, Mark
    Gallop, Robert
    Gastfriend, David R.
    JOURNAL OF SUBSTANCE ABUSE TREATMENT, 2015, 56 : 54 - 60
  • [23] Attitudes toward extended-release naltrexone treatment for opioid use disorder among African Americans
    Rigg, Khary K.
    DRUG AND ALCOHOL DEPENDENCE, 2024, 257
  • [24] The Predictive Value of Degree of Preference for Extended-Release Naltrexone for Treatment Adherence, Opioid Use, and Relapse
    Gaulen, Zhanna
    Brenna, Ida Halvorsen
    Fadnes, Lars Thore
    Benth, Jurate Saltyte
    Solli, Kristin K.
    Kunoe, Nikolaj
    Opheim, Arild
    Tanum, Lars
    EUROPEAN ADDICTION RESEARCH, 2022, 28 (01) : 56 - 67
  • [25] Personal recovery among people with opioid use disorder during treatment with extended-release naltrexone
    Marciuch, Anne
    Birkeland, Bente
    Benth, Jurate Saltyte
    Solli, Kristin Klemmetsby
    Tanum, Lars
    Mathisen, Ida
    Weimand, Bente
    HELIYON, 2023, 9 (07)
  • [26] Transition to Extended-release Naltrexone: Heroin Versus Prescription Opioid Users
    Mannelli, Paolo
    Tompkins, D. Andrew
    Akerman, Sarah
    Yu, Miao
    Nangia, Narinder
    Graham, Christine
    Sullivan, Maria
    Kosten, Thomas
    Bisaga, Adam
    AMERICAN JOURNAL ON ADDICTIONS, 2018, 27 (04): : 323 - 324
  • [27] Efficacy and safety of extended-release injectable naltrexone for the treatment of opioid dependence
    Krupitsky, E.
    Illeperuma, A.
    Gastfriend, D.
    Silverman, B.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2011, 21 : S576 - S576
  • [28] Injectable extended-release naltrexone for the prevention of relapse to opioid dependence following opioid detoxification
    Krupitsky, Evgeny
    NEUROPSYCHIATRY, 2012, 2 (04) : 355 - 362
  • [29] Psychoeducational Strategies During Outpatient Transition to Extended-Release Naltrexone for Patients With Opioid Use Disorder
    Zavod, Abigail
    Akerman, Sarah C.
    Snow, Martha M.
    Tierney, Matt
    Sullivan, Maria A.
    JOURNAL OF THE AMERICAN PSYCHIATRIC NURSES ASSOCIATION, 2019, 25 (04) : 272 - 279
  • [30] Reduced cigarette smoking during injectable extended-release naltrexone treatment for opioid use disorder
    Wang An-Li
    Shi Zhenhao
    Elman, Igor
    Langleben, Daniel D.
    AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE, 2020, 46 (04): : 472 - 477
12345